The highly anticipated results from the CORAL clinical trial wasn’t great news for renal stents, as researchers reported that renal-artery stenting offered "no benefits" over drugs alone in treating patients with atherosclerotic renal-artery stenosis and elevated blood pressure, chronic kidney disease, or both.
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
BioCardia touts positive outcomes for Helical stem cell therapy system
California-based BioCardia Inc. announced this week positive findings from a clinical trial of its Helical Infusion Catheter System for injecting stem cells into the heart in treatment of chronic ischemic cardiomyopathy.
Vascular Solutions signs ‘cooperation agreement’ to get ITGI’s stent on the U.S. market
Replacement heart valves: Real-world results for Sapien equivalent to trial results
Medtronic’s guidewire recall gets FDA’s highest-risk label | MassDevice.com On Call
MASSDEVICE ON CALL — Medical device titan Medtronic (NYSE:MDT) announced late last week that the FDA had put its highest-risk label on a company recall of certain guidewires. The agency deemed the recall a "Class I" issue, reserved for device defects that could "cause serious adverse health consequences or death."
Boston Scientific’s TAVI system hits the German market
Boston Scientific (NYSE:BSX) has officially hit the German market with the 1st commercial patients treated this month, just weeks after the company won CE Mark approval to sell the product in the European Union.
Gore launches Excluder study of iliac branch endoprosthesis
W.L. Gore & Associates this week enrolled its 1st patient in a study of its Excluder iliac branch devices, evaluating the implants in treatment of common iliac artery aneurysms or aorto-iliac aneurysms.
Maintenance of certification in cardiac electrophysiology: Taking the stick
Shuzan, a Buddhist monk of the tenth century, once held up a bamboo stick before his disciples. "Call this a stick," he bellowed, "and you assert; call this not a stick, and you negate. Now, do not assert or negate, what would you call this stick? Speak! Speak!"
Medtronic to resume German CoreValve sales
Edwards Lifesciences boosts valve manufacturing in Singapore
Edwards Lifesciences (NYSE:EW) doubled a heart valve manufacturing facility in Singapore, saying it needs the boost to keep up with growing demand for tissue heart valves.